New Delhi: Zydus Lifesciences on Wednesday said the US health regulator has issued ten observations after inspecting its injection manufacturing plant in Gujarat's Vadodara.
The US Food and Drug Administration (USFDA) inspected the facility at Jarrod Nia Vadodara from April 15 to April 23, the drugmaker said in a regulatory filing.
It said the inspection concluded with ten observations.
Zydus Lifesciences said the company will work closely with the USFDA to promptly address and respond to the comments.
The company's shares were trading 2.79 per cent down at Rs 932.80 on BSE.
The US Food and Drug Administration (USFDA) inspected the facility at Jarrod Nia Vadodara from April 15 to April 23, the drugmaker said in a regulatory filing.
It said the inspection concluded with ten observations.
Zydus Lifesciences said the company will work closely with the USFDA to promptly address and respond to the comments.
The company's shares were trading 2.79 per cent down at Rs 932.80 on BSE.
